دورية أكاديمية
Biomarkers for Hepatocellular Carcinoma-An Updated Review.
| العنوان: | Biomarkers for Hepatocellular Carcinoma-An Updated Review. |
|---|---|
| المؤلفون: | Tekupalli R; Department of Biotechnology, Jnanabharathi Campus, Bangalore University, Bengaluru-560056, Karnataka, India., Anand S; Department of Biotechnology and Genetics, Ramaiah College of Arts, Science & Commerce, Bengaluru-560054, Karnataka, India., Ramachandregowda S; Department of Biotechnology and Genetics, Ramaiah College of Arts, Science & Commerce, Bengaluru-560054, Karnataka, India., Kariyappa AS; Department of Biotechnology, Acharya Bangalore B School, Bengaluru-560091, Karnataka, India., Vadde R; Department of Biotechnology & Bioinformatics, Yogi Vemana University, Kadapa - 516003, Andhra Pradesh, India. |
| المصدر: | Critical reviews in oncogenesis [Crit Rev Oncog] 2021; Vol. 26 (1), pp. 11-20. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Begell House Country of Publication: United States NLM ID: 8914610 Publication Model: Print Cited Medium: Internet ISSN: 0893-9675 (Print) Linking ISSN: 08939675 NLM ISO Abbreviation: Crit Rev Oncog Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: New York, NY : Begell House Original Publication: [Boca Raton, FL : CRC Press, c1989- |
| مواضيع طبية MeSH: | Carcinoma, Hepatocellular*/diagnosis , Carcinoma, Hepatocellular*/genetics , Liver Neoplasms*/diagnosis , Liver Neoplasms*/genetics, Biomarkers, Tumor ; Humans ; Proteomics |
| مستخلص: | Hepatocellular carcinoma (HCC) stands third among cancer-related deaths globally. Owing to its high incidence and linked mortality, early diagnosis is alarming for patient survival and the management of patients with developing HCC requires immediate attention. Advances in the knowledge of cancer biology and recognizing unique molecular candidates, including genomic and proteomic profiles, substantiate our understanding about several biological signatures connected with HCC. Precise identification and differential diagnosis of early HCC can remarkably improve patient survival. Currently, detection of HCC in clinical practice is performed by diagnostic imaging and noninvasive methods such as evaluation of serum biomarkers, growth factors, and the like. In this review, we discuss recent developments in targeting biomarkers for HCC. |
| المشرفين على المادة: | 0 (Biomarkers, Tumor) |
| تواريخ الأحداث: | Date Created: 20210228 Date Completed: 20211130 Latest Revision: 20211130 |
| رمز التحديث: | 20231215 |
| DOI: | 10.1615/CritRevOncog.2020035676 |
| PMID: | 33641281 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 0893-9675 |
|---|---|
| DOI: | 10.1615/CritRevOncog.2020035676 |